272 related articles for article (PubMed ID: 17641777)
1. Muscle-specific knockout of PKC-lambda impairs glucose transport and induces metabolic and diabetic syndromes.
Farese RV; Sajan MP; Yang H; Li P; Mastorides S; Gower WR; Nimal S; Choi CS; Kim S; Shulman GI; Kahn CR; Braun U; Leitges M
J Clin Invest; 2007 Aug; 117(8):2289-301. PubMed ID: 17641777
[TBL] [Abstract][Full Text] [Related]
2. Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι.
Sajan MP; Nimal S; Mastorides S; Acevedo-Duncan M; Kahn CR; Fields AP; Braun U; Leitges M; Farese RV
Metabolism; 2012 Apr; 61(4):459-69. PubMed ID: 22225955
[TBL] [Abstract][Full Text] [Related]
3. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes.
Farese RV; Sajan MP; Standaert ML
Exp Biol Med (Maywood); 2005 Oct; 230(9):593-605. PubMed ID: 16179727
[TBL] [Abstract][Full Text] [Related]
4. PKCλ haploinsufficiency prevents diabetes by a mechanism involving alterations in hepatic enzymes.
Sajan MP; Ivey RA; Lee M; Mastorides S; Jurczak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
Mol Endocrinol; 2014 Jul; 28(7):1097-107. PubMed ID: 24877563
[TBL] [Abstract][Full Text] [Related]
5. The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity.
Sajan MP; Standaert ML; Nimal S; Varanasi U; Pastoor T; Mastorides S; Braun U; Leitges M; Farese RV
J Lipid Res; 2009 Jun; 50(6):1133-45. PubMed ID: 19202134
[TBL] [Abstract][Full Text] [Related]
6. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-lambda knockout in embryonic stem cells and adipocytes impairs insulin-stimulated glucose transport.
Bandyopadhyay G; Standaert ML; Sajan MP; Kanoh Y; Miura A; Braun U; Kruse F; Leitges M; Farese RV
Mol Endocrinol; 2004 Feb; 18(2):373-83. PubMed ID: 14615604
[TBL] [Abstract][Full Text] [Related]
8. Effects of adenoviral gene transfer of wild-type, constitutively active, and kinase-defective protein kinase C-lambda on insulin-stimulated glucose transport in L6 myotubes.
Bandyopadhyay G; Kanoh Y; Sajan MP; Standaert ML; Farese RV
Endocrinology; 2000 Nov; 141(11):4120-7. PubMed ID: 11089544
[TBL] [Abstract][Full Text] [Related]
9. Reduced glucose uptake precedes insulin signaling defects in adipocytes from heterozygous GLUT4 knockout mice.
Li J; Houseknecht KL; Stenbit AE; Katz EB; Charron MJ
FASEB J; 2000 Jun; 14(9):1117-25. PubMed ID: 10834933
[TBL] [Abstract][Full Text] [Related]
10. Atypical protein kinase C in cardiometabolic abnormalities.
Farese RV; Sajan MP
Curr Opin Lipidol; 2012 Jun; 23(3):175-181. PubMed ID: 22449812
[TBL] [Abstract][Full Text] [Related]
11. Effects of knockout of the protein kinase C beta gene on glucose transport and glucose homeostasis.
Standaert ML; Bandyopadhyay G; Galloway L; Soto J; Ono Y; Kikkawa U; Farese RV; Leitges M
Endocrinology; 1999 Oct; 140(10):4470-7. PubMed ID: 10499500
[TBL] [Abstract][Full Text] [Related]
12. Effects of transiently expressed atypical (zeta, lambda), conventional (alpha, beta) and novel (delta, epsilon) protein kinase C isoforms on insulin-stimulated translocation of epitope-tagged GLUT4 glucose transporters in rat adipocytes: specific interchangeable effects of protein kinases C-zeta and C-lambda.
Bandyopadhyay G; Standaert ML; Kikkawa U; Ono Y; Moscat J; Farese RV
Biochem J; 1999 Feb; 337 ( Pt 3)(Pt 3):461-70. PubMed ID: 9895289
[TBL] [Abstract][Full Text] [Related]
13. Insulin-stimulated plasma membrane association and activation of Akt2, aPKC zeta and aPKC lambda in high fat fed rodent skeletal muscle.
Herr HJ; Bernard JR; Reeder DW; Rivas DA; Limon JJ; Yaspelkis BB
J Physiol; 2005 Jun; 565(Pt 2):627-36. PubMed ID: 15802290
[TBL] [Abstract][Full Text] [Related]
14. Metabolism and insulin signaling in common metabolic disorders and inherited insulin resistance.
Højlund K
Dan Med J; 2014 Jul; 61(7):B4890. PubMed ID: 25123125
[TBL] [Abstract][Full Text] [Related]
15. Skeletal muscle insulin resistance in obesity-associated type 2 diabetes in monkeys is linked to a defect in insulin activation of protein kinase C-zeta/lambda/iota.
Standaert ML; Ortmeyer HK; Sajan MP; Kanoh Y; Bandyopadhyay G; Hansen BC; Farese RV
Diabetes; 2002 Oct; 51(10):2936-43. PubMed ID: 12351430
[TBL] [Abstract][Full Text] [Related]
16. Impairment of insulin-stimulated glucose transport and ERK activation by adipocyte-specific knockout of PKC-λ produces a phenotype characterized by diminished adiposity and enhanced insulin suppression of hepatic gluconeogenesis.
Sajan MP; Jurzak MJ; Samuels VT; Shulman GI; Braun U; Leitges M; Farese RV
Adipocyte; 2014 Jan; 3(1):19-29. PubMed ID: 24575365
[TBL] [Abstract][Full Text] [Related]
17. Repletion of atypical protein kinase C following RNA interference-mediated depletion restores insulin-stimulated glucose transport.
Sajan MP; Rivas J; Li P; Standaert ML; Farese RV
J Biol Chem; 2006 Jun; 281(25):17466-17473. PubMed ID: 16644736
[TBL] [Abstract][Full Text] [Related]
18. Contrasting insulin dose-dependent defects in activation of atypical protein kinase C and protein kinase B/Akt in muscles of obese diabetic humans.
Casaubon L; Sajan MP; Rivas J; Powe JL; Standaert ML; Farese RV
Diabetologia; 2006 Dec; 49(12):3000-8. PubMed ID: 17028898
[TBL] [Abstract][Full Text] [Related]
19. Defective insulin-induced GLUT4 translocation in skeletal muscle of high fat-fed rats is associated with alterations in both Akt/protein kinase B and atypical protein kinase C (zeta/lambda) activities.
Tremblay F; Lavigne C; Jacques H; Marette A
Diabetes; 2001 Aug; 50(8):1901-10. PubMed ID: 11473054
[TBL] [Abstract][Full Text] [Related]
20. Rosiglitazone, insulin treatment, and fasting correct defective activation of protein kinase C-zeta/lambda by insulin in vastus lateralis muscles and adipocytes of diabetic rats.
Kanoh Y; Bandyopadhyay G; Sajan MP; Standaert ML; Farese RV
Endocrinology; 2001 Apr; 142(4):1595-605. PubMed ID: 11250941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
